Clover Biopharmaceuticals has ended its partnership with GlaxoSmithKline Plc (GSK.L) to develop a COVID-19 vaccine using its adjuvant, the Chinese drugmaker said on Monday, as it will stick with a ...
Fiserv is one of the world’s largest providers of financial technology infrastructure and is a constituent of the S&P 500 ...
When deciding between a countertop and a portable POS, businesses should evaluate their specific needs and operational ...
Lightspeed Commerce struggles with slowing growth, falling multiples, and rising competition from larger peers, dimming its ...
New integration enables loan officers to shop rates, validate eligibility and manage locks within Horizon's Loan Center - ...
Fiserv, Inc. (NYSE:FI) is one of the stocks Jim Cramer recently talked about. During the episode, a caller asked what Cramer thinks of the stock, and he replied: “I gotta tell you, that was not a good ...
bne IntelliNews on MSN
Nigeria’s CBN bans multi-operator PoS model to streamline agent banking
Nigeria’s Central Bank (CBN) has issued new rules that will bar point-of-sale (PoS) agents from operating under multiple ...
Clover Biopharmaceuticals is seeking to conduct late-stage clinical trials in the Philippines of its coronavirus vaccine, the country's foods and drugs agency chief said on Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback